Stocks analysis

AEE vs ALL Stock Comparison

Scores Breakdown

Metric AEE ALL
šŸ“ˆ Growth 0/30 22/30
šŸ’° Profitability 12/20 14/20
šŸ¦ Financial Health 14/20 18/20
šŸ’µ Valuation 12/20 10/20
āš ļø Risk (lower is better) 7/10 6/10
Overall Score 41/100 68/100

Side-by-Side Summaries

AEE Analysis ALL Analysis

šŸ“ˆ Growth & Financial Trajectory

Over eight quarters, Ameren's revenue progressed from $2.173B in 2024 Q2 to $2.176B in 2026 Q1, essentially flat. A standout spike occurred in 2025 Q3 at $2.699B, followed by a dip to $1.782B in 2025 Q4, then a return toward $2.2B. Net income moved unevenly, starting at $457M (Q2 2024) and ending at $358M (Q1 2026), with a peak of $640M in 2025 Q3.

šŸ’° Margins & Cash Flow

Operating margins fluctuated, averaging around 24.6%, peaking at 39.3% (2025 Q1) and dipping to 10.2% (2024 Q4). Cash flow: net cash from operating activities was generally positive; investing activities were typically negative, and financing activity provided offsetting support in several quarters. The quarterly cadence yields solid operating cash flow in aggregate, aligning with a capital-intensive utility model.

šŸ›”ļø Balance Sheet & Liquidity

Total assets run near $49.8B with liabilities around $36.2B and equity of about $13.6B. Long-term debt sits near $19.4B, indicating a moderate debt load for a regulated utility. The balance sheet remains constructive, supported by recurring operating cash flows.

āš ļø Key Drivers & Risks

  • Drivers: Regulated utility framework and stable dividend policy; cash-flow visibility from rate cases.
  • Risks: Regulatory changes and weather-driven demand variability; interest-rate and valuation sensitivity.

šŸ“ˆ Growth & Financial Trajectory

Across 8 quarters, Allstate’s revenue rose from about $15.714B (2024-Q2) to about $16.941B (2026-Q1), up roughly 7.8%. Net income climbed from about $0.347B to $2.458B, a multi‑fold increase, with a notable surge in late‑2025 before a softer start in 2026.

The trend is positive overall but shows quarterly volatility (e.g., 2025‑Q1 dip followed by stronger 2025‑Q3/Q4). End‑period profitability remains sensitive to cost structure and mix, yet margins improved from multi‑quarter lows to mid‑teens late in 2025 and into 2026.

šŸ’° Margins & Cash Flow

  • Operating margin ranged from about 2.7% (2024‑Q2) to about 28.4% (2025‑Q4), with several quarters in the mid‑teens, indicating substantial margin volatility but a capability to leverage scale when costs align with revenues.
  • Net cash flow from operating activities remained positive in all quarters, averaging around $3.0B per quarter; notably, 2026‑Q1 shows operating cash flow near $3.56B.
  • Investing cash flow was often negative, reflecting capital allocation and reserve considerations, while financing activity flow fluctuated, contributing to variances in overall cash balance.

šŸ›”ļø Balance Sheet & Liquidity

  • Current assets consistently exceed current liabilities, yielding a healthy current ratio around 1.3x (roughly 1.29–1.34 over periods).
  • Long‑term debt sits near $8.08B with total liabilities largely dominated by insurance reserves and operating liabilities, while equity (ā‰ˆ$21–31B across periods) provides a meaningful buffer; periods show equity around $24–31B and liabilities near $92–93B.

āš ļø Key Drivers & Risks

  • Drivers: prudent pricing and reserving practices within P&C insurance; managing catastrophe exposure and capital allocation.
  • Risks: quarterly earnings are sensitive to claim volatility and reserve adequacy; macro factors and regulatory changes can impact pricing and claims experience, affecting valuation sensitivity and downside scenarios.